Strides Pharma Science Limited has informed the Exchange regarding request received for promoter reclassification.
STAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Strides Pharma Science, at its meeting on May 22, 2025, approved a request from Shasun Enterprises LLP and Ambemata Securities (together called 'Outgoing Promoters') to be reclassified from the 'Promoter Group' to the 'Public' category. This follows an earlier intimation dated May 15, 2025. The reclassification is being done under Regulation 31A of SEBI Listing Regulations, and the company will now file the application with the stock exchanges for approval. No specific share counts or percentage figures were disclosed in this filing.
Once the reclassification is approved by the exchanges, the shareholding of these two entities will shift from promoter holding to public shareholding. This is a structural/classification change rather than a sale of shares, so it does not impact the company's business or valuation, but it will reduce the official promoter group's shareholding and increase the public shareholding count.